⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
U.S. FDA Accepts Gilead’s Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention
businesswire.com
GILD
Next Generation Drug Conjugates Market Expected to Reach USD 42.55 Billion by 2035 | MarketsandMarkets™
globenewswire.com
AZN
NVS
ALNY
GILD
ABBV
IONS
SNY
Marquis Who's Who Interviews and Honors Guy Plunkett III, PhD, for Excellence in Bacteriology, Genomics and Higher Education
accessnewswire.com
ALGN
CRIS
REGN
GILD
AMGN
BIIB
VRTX
ILMN
NTLA
EDIT
EXAS
PACB
NVDA
AMD
INTC
MU
GOOG
MSFT
IBM
ORCL
CRM
ADBE
CSCO
ACN
BABA
JD
PDD
BIDU
IQ
HTHT
XPEV
NIO
LI
TSLA
RIVN
LCID
F
GM
STLA
VWAGY
TM
HMC
AGNC
PLTR
SNOW
DDOG
SMCI
ASML
KLAC
LRCX
AMAT
ADI
TXN
QCOM
MCHP
NXPI
ON
INFY
WIT
SAP
HPQ
DELL
MSI
AVGO
MRVL
WDC
SE
BILI
EDU
RLX
BEKE
TAL
Patient Monitoring Devices Market worth $76.11 billion by 2031 | MarketsandMarkets™
prnewswire.com
MDT
ABT
DXCM
GEHC
BSX
MASI
BIIB
AMGN
GILD
BMY
MRK
PFE
JNJ
BAX
BOSC
Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition
globenewswire.com
ABBV
LLY
MRK
NVS
PFE
SNY
GILD
BMY
JNJ
UCB
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight
globenewswire.com
AZN
NVS
ABBV
BMY
GILD
REGN
VRTX
BIIB
JNJ
MRK
ARWR
TAK
VERA
TransCelerate Receives DIA Global Inspire Award and Showcases Collaborative Innovation at DIA 2026
prnewswire.com
NVS
GILD
Retool Achieves AWS Consumer Goods Competency
businesswire.com
AMZN
COIN
DDOG
ADBE
NFLX
AAPL
GOOG
CHTR
NVDA
MSFT
INTC
AMD
TSLA
META
CRM
IBM
ORCL
CSCO
ACN
PYPL
UPST
PLTR
SNOW
CRWD
PANW
ZS
MDB
AFRM
SOFI
UPWK
FIVN
DOCU
SMCI
ASML
AMAT
KLAC
LRCX
MU
WDC
NXPI
QCOM
MRVL
ADSK
CDNS
SNPS
AMGN
GILD
BMY
LLY
REGN
VRTX
BIIB
AZN
XOM
CVX
SHEL
T
VZ
TMUS
CMCSA
DIS
GOOGL
As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over Antibodies
accessnewswire.com
NNVC
GILD
Dualitas Therapeutics Appoints Karim Dabbagh as Chief Executive Officer to Advance Novel Bispecific Antibody Pipeline Toward the Clinic
prnewswire.com
GILD